Showing results (11-20 of 82) with videos related to
Sort By:
Pageof 9
Zeitschrift Fur Rheumatologie|December 10, 2016
[De-escalation of therapy in ANCA-associated vasculitides]S Schinke, G Riemekasten, P LamprechtVASA. Zeitschrift Fur Gefasskrankheiten|February 2, 2011
Systemic sclerosis - a systematic overview: part 1 - disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillanceP Klein-Weigel, C Opitz, G RiemekastenZeitschrift Fur Rheumatologie|February 14, 2015
[Regulatory T cells and rheumatic diseases]J Y Humrich, T Kamradt, G RiemekastenZeitschrift Fur Rheumatologie|September 27, 2018
[Mimetics of systemic sclerosis]S T Jendrek, B Kahle, G RiemekastenZeitschrift Fur Rheumatologie|July 14, 2009
[Pulmonary arterial hypertension in collagenoses]M Claussen, G Riemekasten, M M HoeperVASA. Zeitschrift Fur Gefasskrankheiten|February 2, 2011
Systemic sclerosis - a systematic overview: part 2 - immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertensionC Opitz, P F Klein-Weigel, G RiemekastenZeitschrift Fur Rheumatologie|May 22, 2010
[Towards an implementation of guidelines for the therapy of systemic sclerosis (scleroderma): between desire and reality]M O Becker, U Müller-Ladner, G RiemekastenBehavioural Pharmacology|March 1, 1995
The effects of selective and non-selective monoamine oxidase (MAO) inhibitors on conflict behavior in the ratR.L. Commissaris, J. Humrich, J. Johns, et al.Zeitschrift Fur Rheumatologie|June 17, 1998
[Iloprost administration over 21 days as an effective therapy in systemic scleroderma--case report and review of the literature]G Riemekasten, H Jepsen, G R Burmester, et al.Clinical and Experimental Rheumatology|August 2, 2003
Non organ based laboratory markers in systemic sclerosisN J McHugh, O Distler, R Giacomelli, et al.Pageof 9